The ejection fraction measured by echocardiography improved from 30 to 38% in group 1, from 31 to 45% in group 2a and from 30 to 35% in group 2b ( p <0.05). Addition of LEV was associated with significant reduction of NYHA class and bodyweight in all groups. No adverse side effects...